SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
8-K	Report of unscheduled material events or corporate event	May 03, 2023	View HTML 0000950170-23-016879.pdf 0000950170-23-016879.rtf 0000950170-23-016879.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-Q	Quarterly report which provides a continuing view of a company's financial position	May 04, 2023	View HTML 0000950170-23-017724.pdf 0000950170-23-017724.rtf 0000950170-23-017724.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
4	Statement of changes in beneficial ownership of securities	May 15, 2023	View HTML 0001562180-23-004132.pdf 0001562180-23-004132.rtf 0001562180-23-004132.xls
8-K	Report of unscheduled material events or corporate event	May 18, 2023	View HTML 0000950170-23-022872.pdf 0000950170-23-022872.rtf 0000950170-23-022872.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K/A	Amendment to a previously filed 8-K	May 23, 2023	View HTML 0001193125-23-151951.pdf 0001193125-23-151951.rtf 0001193125-23-151951.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	May 26, 2023	View HTML 0001968940-23-000001.pdf 0001968940-23-000001.rtf
144/A	Amendment to a previously filed 144	May 26, 2023	View HTML 0001840315-23-000004.pdf 0001840315-23-000004.rtf 0001840315-23-000004.xls
144/A	Amendment to a previously filed 144	May 26, 2023	View HTML 0001840315-23-000005.pdf 0001840315-23-000005.rtf 0001840315-23-000005.xls
4	Statement of changes in beneficial ownership of securities	May 30, 2023	View HTML 0001562180-23-004580.pdf 0001562180-23-004580.rtf 0001562180-23-004580.xls
4	Statement of changes in beneficial ownership of securities	May 30, 2023	View HTML 0001562180-23-004579.pdf 0001562180-23-004579.rtf 0001562180-23-004579.xls

Data provided by Kaleidoscope.